Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRG | P62508 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 7/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20968297 | 0.92 | ESRRG (0.50) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968395 | 0.89 | GCGR (0.53) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968256 | 0.88 | MAPT (0.41) | ESRRGNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL20968380 | 0.87 | NPC1 (0.49) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968354 | 0.84 | ESRRG (0.58) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968393 | 0.83 | NPC1 (0.56) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968351 | 0.82 | ESRRG (0.53) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968356 | 0.81 | GCGR (0.52) | ESRRGNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL20968358 | 0.80 | PIK3CG (0.39) | ESRRGNPC1RAB9AMEN1KMT2A | |
| SCHEMBL20968353 | 0.77 | NPC1 (0.55) | ESRRGNPC1RAB9ACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | JNC CORPORATION (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20190127643-A1 | LIQUID CRYSTAL ALIGNING AGENT FOR PHOTOALIGNMENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING IT, AND DIAMINE AND POLYMER | JNC CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | DDT, DCLRE1A, DVL1 | ESRRG 4848/4885NPC1 4833/4885RAB9A 1320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.